Walleye Capital
CVS icon

Walleye Capital’s CVS Health CVS Stock Holding History

Walleye Capital’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.74M Sell
65,200
-74,900
-53% -$6.69M 0.02% 659
2026
Q1 		$10.1M Sell
140,100
-40,100
-22% -$3.09M 0.04% 396
2025
Q4 		$14.3M Buy
180,200
+84,500
+88% +$6.66M 0.04% 431
2025
Q3 		$7.21M Sell
95,700
-48,700
-34% -$3.34M 0.03% 710
2025
Q2 		$9.96M Sell
144,400
-47,700
-25% -$3.13M 0.04% 501
2025
Q1 		$13M Sell
192,100
-25,300
-12% -$1.51M 0.06% 330
2024
Q4 		$9.76M Sell
217,400
-96,400
-31% -$5.41M 0.02% 644
2024
Q3 		$19.7M Buy
313,800
+233,400
+290% +$13.6M 0.04% 333
2024
Q2 		$4.75M Sell
80,400
-11,700
-13% -$732K 0.01% 1330
2024
Q1 		$7.35M Sell
92,100
-18,400
-17% -$1.41M 0.01% 1038
2023
Q4 		$8.73M Sell
110,500
-28,400
-20% -$2.02M 0.02% 738
2023
Q3 		$9.7M Buy
138,900
+21,400
+18% +$1.52M 0.02% 590
2023
Q2 		$8.12M Buy
117,500
+102,800
+699% +$7.31M 0.03% 479
2023
Q1 		$1.09M Sell
14,700
-300
-2% -$25.2K 0.02% 1099
2022
Q4 		$1.4M Hold
15,000
– – 0.03% 783
2022
Q3 		$1.43M Buy
+15,000
New +$1.48M 0.03% 734
2020
Q1 		– Sell
-34,000
Closed -$2.53M – 1071
2019
Q4 		$2.53M Sell
34,000
-103,000
-75% -$7.23M 0.16% 151
2019
Q3 		$8.64M Buy
137,000
+116,800
+578% +$6.92M 0.51% 18
2019
Q2 		$1.1M Buy
20,200
+15,100
+296% +$813K 0.12% 236
2019
Q1 		$275K Buy
+5,100
New +$315K 0.05% 636

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Walleye Capital's CVS Position: Q2 2026 in Review

Walleye Capital increased its CVS Health (CVS) stake by 89,245% in Q2 2026, buying an estimated $72.6M and bringing the position to 813,936 shares worth $84.2M. The position accounts for 0.3% of the portfolio, ranked #33.

Walleye Capital first reported a position in CVS in Q3 2021 and has held it in 14 quarters since. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Walleye Capital held 813,936 shares of CVS Health worth $84.2M as of Q2 2026.
  • Walleye Capital bought 813,025 CVS Health shares in Q2 2026, an estimated $72.6M.
  • CVS Health made up 0.3% of Walleye Capital's portfolio in Q2 2026, its #33 holding.
  • Walleye Capital first reported a position in CVS Health in Q3 2021 and has held it in 14 quarters since.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.